Evidence map›Paper›PMID 39124898›Full record

ReviewMolecules (Basel, Switzerland)2024

Exploring the Potential of Microbial Coalbed Methane for Sustainable Energy Development.

Yu Niu, Zhiqian Wang, Yingying Xiong, Yuqi Wang, Lin Chai, Congxiu Guo

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Frontiers in bioengineering and biotechnology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yu NiuSchool of Electric Power, Civil Engineering and Architecture, Shanxi University, Taiyuan 030006, China.ORCID 0000-0002-2060-5926
Zhiqian WangSchool of Electric Power, Civil Engineering and Architecture, Shanxi University, Taiyuan 030006, China.ORCID 0009-0002-2591-9622
Yingying XiongSchool of Electric Power, Civil Engineering and Architecture, Shanxi University, Taiyuan 030006, China.
Yuqi WangSchool of Electric Power, Civil Engineering and Architecture, Shanxi University, Taiyuan 030006, China.
Lin ChaiBeijing Key Laboratory of Green Chemical Reaction Engineering and Technology, Department of Chemical Engineering, Tsinghua University, Beijing 100084, China.
Congxiu GuoSchool of Electric Power, Civil Engineering and Architecture, Shanxi University, Taiyuan 030006, China.

Funding

Shanxi Province Basic Research Program 202103021223031
6 · The paper itself

Abstract

By allowing coal to be converted by microorganisms into products like methane, hydrogen, methanol, ethanol, and other products, current coal deposits can be used effectively, cleanly, and sustainably. The intricacies of in situ microbial coal degradation must be understood in order to develop innovative energy production strategies and economically viable industrial microbial mining. This review covers various forms of conversion (such as the use of MECoM, which converts coal into hydrogen), stresses, and in situ use. There is ongoing discussion regarding the effectiveness of field-scale pilot testing when translated to commercial production. Assessing the applicability and long-term viability of MECoM technology will require addressing these knowledge gaps. Developing suitable nutrition plans and utilizing lab-generated data in the field are examples of this. Also, we recommend directions for future study to maximize methane production from coal. Microbial coal conversion technology needs to be successful in order to be resolved and to be a viable, sustainable energy source.

Indexed as

biodegradation of coalbiomethaneMECoMmicrobial transformationsustainable energy development

Identifiers

PMID39124898
PMCPMC11313768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.